Given the similar oncogenic roles of ZIP4, these strategies could also be applicable to ZIP4, providing a potential strategy for targeted therapies in cancers such as breast and colorectal cancer, which are highly prevalent in the Saudi population. This evidence concerns the gene SLC39A4 and cancer.